Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-05-28 @ 9:37 AM
Study NCT ID:
NCT00851318
Status:
COMPLETED
Last Update Posted:
2014-11-03
First Post:
2009-02-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
Sponsor:
Astellas Pharma Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CDP870-275-08-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |